National Health Investors... (NHI)
Bid | 78.32 |
Market Cap | 3.78B |
Revenue (ttm) | 349.38M |
Net Income (ttm) | 142.93M |
EPS (ttm) | 3.14 |
PE Ratio (ttm) | 25.36 |
Forward PE | 24.33 |
Analyst | Buy |
Dividends | $3.62 |
Ask | 80.51 |
Volume | 130,652 |
Avg. Volume (20D) | 235,771 |
Open | 79.78 |
Previous Close | 79.47 |
Day's Range | 79.47 - 80.56 |
52-Week Range | 65.13 - 85.22 |
Beta | 0.79 |
Ex-Dividend Date | Sep 30, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NHI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAnalysts project revenue of ... Unlock content with Pro Subscription

1 month ago · seekingalpha.com
National HealthCare Is Thriving And Will Shrug Off NHI Lease ExpirationNHC's fundamentals are robust, with strong earnings, revenue, and margin growth. Despite recent underperformance in total return, operating margins have expanded significantly and are likely to contin...

1 month ago · seekingalpha.com
National Health Investors: 5% Yield And Robust Growth In Plain SightNational Health Investors offers attractive growth and income, with robust SHOP margins, improving rent coverage, and accelerating portfolio transitions fueling FFO and NOI expansion. NHI's strong bal...

1 month ago · seekingalpha.com
National Health Investors, Inc. (NHI) Q2 2025 Earnings Call TranscriptNational Health Investors, Inc. (NYSE:NHI ) Q2 2025 Earnings Conference Call August 7, 2025 10:00 AM ET Company Participants D. Eric Mendelsohn - President, CEO & Director Dana Rolfson Hambly - Vice P...